Answers are grounded in this paper and cite their sources.
Selective androgenic receptor modulators (SARMs) have not been approved by the U.S. Food and Drug Administration but they are heavily promoted as alternatives to androgenic anabolic steroids. We present two cases of liver injury associated with SARMs.
No takes yet. Share an insight, caveat, or question.
Flores et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: